Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
18,383,012
-
Shares change
-
-65,340
-
Total reported value, excl. options
-
$212,366,897
-
Value change
-
-$903,981
-
Put/Call ratio
-
46.3%
-
Number of buys
-
55
-
Number of sells
-
-24
-
Price
-
$11.55
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q3 2017
104 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q3 2017.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,383,012 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (5,032,313 shares), FMR LLC (2,731,342 shares), BlackRock Inc. (2,350,761 shares), JPMORGAN CHASE & CO (2,263,108 shares), VANGUARD GROUP INC (1,212,275 shares), STATE STREET CORP (430,457 shares), Point72 Asset Management, L.P. (408,900 shares), MORGAN STANLEY (370,667 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (370,193 shares), and NORTHERN TRUST CORP (343,775 shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.